ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 

ISTH 2020 Congress

Platelet Disorders and von Willebrand Disease » Platelet Antagonists and Novel Therapeutics

Theme Navigation

Abstract Number: PB1469

Antithrombotic Therapy by Charged Nanoparticles

M. Griffin1, K. Ashworth2, J. Di Paola2, D. Ku1

Abstract Number: PB1455

High-Dose Dexamethasone Effectively Replaces Traditional Full-Dose Prednisone as the First-Line Treatment of Children Immune Thrombocytopenia: A Prospective Randomized Single-Center Study

L. Fu, J. Ma, J. Ma, H. Gu, Z. Chen, R. Wu

Abstract Number: PB1467

Idelalisib Selectively Inhibits GPVI-mediated Platelet Activation and Shows Anti-atherothrombotic Activity

M. Nuñez Barrachina1, I. Izquierdo1, L. Hermida-Nogueira1, L. A. Morán1, A. B. Arroyo2, N. García-Barberá2, R. González-Conejero2, J. Rivera2, C. Martínez2, M. I. Loza3, E. Domínguez3, Á. García1

Abstract Number: PB1459

Identification of the Sequence Specificity in C-Src SH3 Required for Binding to Integrin Β3 as a Novel Anti-Thrombotic Target without Compromising Primary Hemostasis

J. Mao1, Y. Wang1, B. Xiao1, Z. Long1, K. Zhu2, J. Liu2, Z. Ruan1, W. Xi1, C. Luo2, X. Xi1

Abstract Number: PB1460

Inhibition of Platelet Adhesion, Thrombus Formation and Fibrin Formation by a Potent αIIbβ3 Integrin Inhibitor

D.L. van den Kerkhof, M. Nagy, J.W.M. Heemskerk, T.M. Hackeng, I. Dijkgraaf

Abstract Number: PB1466

Method of Anticoagulation Influences Potency of Reversible P2Y12 Receptor Antagonists

M. Baumann, M.A. Riederer

Abstract Number: PB/LB05

Phase 2 Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia

A.C. Newland1, B. Sanchez-Gonzalez2, L. Rejtő3, M. Egyed4, N. Romanyuk5, M. Godar6, K. Verschueren6, D. Gandini6, P. Ulrichts6, J. Beauchamp6, T. Dreier6, S. Ward7, M. Michel8, H.A. Liebman9, H. de Haard6, N. Leupin6, D. Kuter10

Abstract Number: PB1468

Role of Multidrug Resistance Protein 4 on Both Platelet Nitric Oxide Resistance and ADP Induced Platelet Aggregation

M.L. Guarino1, I. Massimi1, L. Alemanno1, L. Conti2, D.J. Angiolillo3, F.M. Pulcinelli1

Abstract Number: PB1465

Selatogrel, a Potent P2Y12 Receptor Antagonist, Dissolves Pre-Formed Platelet-thrombi in vivo

L. Crescence1, M. Kramberg2, M. Baumann3, M. Rey2, L. Panicot-Dubois1, C. Dubois1, M.A. Riederer3

Abstract Number: PB1458

Tyrosine Kinase Inhibitors (TKIs) Targeting Syk and BTK Signaling Differentially Affect PI3K Organization and Inhibit Platelet Function

T. Zheng, E. Lofurno, A. Melrose, J. Pang, J. Shatzel, O. McCarty, J. Aslan

« View all themes from the ISTH 2020 Congress